Co-Diagnostics, Inc. announced that it has made several strategic additions to its Scientific Advisory Board ("SAB"). The Company welcomes Carl Wittwer, M.D., Ph.D. as Chairman, and Karen C. Carroll, M.D, Noriko Kusukawa, Ph.D., and Anne Wyllie, Ph.D. who join Company co-founder Brent Satterfield, Ph.D. on the SAB. Dr. Carroll is a Professor of Pathology and Director of the Division of Medical Microbiology at Johns Hopkins University School of Medicine, and a Fellow of the American Academy of Microbiology, the Infectious Diseases Society of America, and the College of American Pathologists.

Dr. Kusukawa is a 35-year veteran of biotech and healthcare industries. She has worked in the United States and Japan directing strategic investments in new technology. Most recently, she served as vice president for ARUP Laboratories (University of Utah) and as adjunct associate professor of pathology.

Dr. Wyllie, is a Research Scientist and Principal Investigator of SalivaDirect at Yale University. Having worked with saliva as a clinical specimen for bacterial detection for almost 10 years, Dr. Wyllie is an expert in the laboratory methods required for working with saliva and skillfully applied these early in the pandemic for sensitive SARS-CoV-2 detection, and has since become well-recognized for pushing forward on the use of saliva as a superior sample for creating high-quality, low-cost SARS-CoV-2 testing.